Al's Comment:

This is a good sign - no safety problems identified and the trial will be allowed to continue until it completes.

---

Posted on: 10/02/2017

VBL Therapeutics Announces Positive Outcome in the Third and Final DSMC Review of Phase 3 GLOBE Trial Investigating VB-111 in Recurrent GBM

 

---

Click HERE to return to brain tumor news headlines.